Ruconest
NDC 71274-350, c1 esterase inhibitor recombinant, injection, powder, for solution, from Pharming Healthcare Inc..
- Product NDC
- 71274-350
- Status
- Listed
- Labeler
- Pharming Healthcare Inc.
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125495
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71274-350 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CONESTAT ALFA2100 U/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71274-350-02 | 71274035002 | 1 VIAL, SINGLE-USE in 1 CARTON (71274-350-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE (71274-350-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/66d3fecb-32a4-7781-e053-2a91aa0a83caMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=71274-350
Use it
Look up 71274-350 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71274-350 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71274-350. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.